Biotech Short Candidates Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (657)	5/6/2004 1:17:00 PM
From: zeta1961	Read Replies (1) of 897

>>>ONXX<<<< If you ask me...bay-whatever molecule they are making has to be one of the most overhyped molecules in biocancer today....Yes they are showing up at ASCO.......how can they justify this price when the molecule has shown marginal efficacy? The deal is that raf kinase inhibitors are the rage this year at ASCO....just received my pre-ASCO educational book....1.5 inches thick....this class of compounds is discussed all over the place in just about every major cancer.........maybe I'm talking from the microphone of someone who missed the onxx runup....but I've looked at their studies and nothing about them made me want to put a dime in this company... Rant over, Zeta

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next